ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 129 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2017. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $54,000 | -3.6% | 10,045 | +0.4% | 0.03% | -46.4% |
| Q3 2016 | $56,000 | -62.4% | 10,000 | -50.1% | 0.06% | -72.5% |
| Q1 2016 | $149,000 | +79.5% | 20,045 | +99.6% | 0.20% | +300.0% |
| Q4 2015 | $83,000 | -75.7% | 10,045 | -64.6% | 0.05% | -75.9% |
| Q2 2015 | $341,000 | -62.8% | 28,408 | -66.6% | 0.21% | -65.4% |
| Q1 2015 | $917,000 | +201.6% | 85,090 | +41.8% | 0.61% | +273.2% |
| Q4 2014 | $304,000 | +1069.2% | 60,000 | +500.0% | 0.16% | +811.1% |
| Q3 2014 | $26,000 | -35.0% | 10,000 | 0.0% | 0.02% | -28.0% |
| Q2 2014 | $40,000 | -65.2% | 10,000 | -60.0% | 0.02% | -59.7% |
| Q1 2014 | $115,000 | +5.5% | 25,000 | 0.0% | 0.06% | +17.0% |
| Q4 2013 | $109,000 | -44.9% | 25,000 | -50.0% | 0.05% | -55.8% |
| Q3 2013 | $198,000 | +465.7% | 50,000 | +199.4% | 0.12% | +380.0% |
| Q2 2013 | $35,000 | – | 16,700 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MSD Partners, L.P. | 10,986,258 | $20,544,000 | 1.80% |
| Third Security, LLC | 4,364,080 | $8,161,000 | 1.11% |
| MILLER VALUE PARTNERS, LLC | 9,264,700 | $16,617,000 | 0.75% |
| Sargent Investment Group, LLC | 188,950 | $353,000 | 0.22% |
| Chessman Wealth Strategies RIA | 72,050 | $135,000 | 0.14% |
| Ibex Investors LLC | 403,650 | $755,000 | 0.12% |
| Old West Investment Management, LLC | 223,319 | $417,000 | 0.11% |
| PIPER SANDLER & CO. | 34,222 | $64,000 | 0.07% |
| Virtus ETF Advisers LLC | 102,888 | $192,000 | 0.03% |
| G&S Capital LLC | 18,000 | $34,000 | 0.03% |